JPH0481962B2 - - Google Patents
Info
- Publication number
- JPH0481962B2 JPH0481962B2 JP4803285A JP4803285A JPH0481962B2 JP H0481962 B2 JPH0481962 B2 JP H0481962B2 JP 4803285 A JP4803285 A JP 4803285A JP 4803285 A JP4803285 A JP 4803285A JP H0481962 B2 JPH0481962 B2 JP H0481962B2
- Authority
- JP
- Japan
- Prior art keywords
- glycyrrhetin
- glycoside
- glycyrrhizin
- present
- arbutin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 claims description 22
- 229930182470 glycoside Natural products 0.000 claims description 15
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 claims description 12
- 229960003720 enoxolone Drugs 0.000 claims description 12
- 150000002338 glycosides Chemical class 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 11
- 239000004378 Glycyrrhizin Substances 0.000 description 11
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 11
- 229960004949 glycyrrhizic acid Drugs 0.000 description 11
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 11
- 235000019410 glycyrrhizin Nutrition 0.000 description 11
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 229960000271 arbutin Drugs 0.000 description 10
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 10
- -1 hydroquinone glycoside Chemical class 0.000 description 9
- 230000003110 anti-inflammatory effect Effects 0.000 description 7
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N 1,4-Benzenediol Natural products OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 4
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 4
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 4
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 235000015961 tonic Nutrition 0.000 description 4
- 230000001256 tonic effect Effects 0.000 description 4
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 3
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical group OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Chemical group OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N beta-monoglyceryl stearate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 150000002337 glycosamines Chemical group 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 229960000716 tonics Drugs 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- CRBBOOXGHMTWOC-NPDDRXJXSA-N 1,4-Anhydro-6-O-dodecanoyl-2,3-bis-O-(2-hydroxyethyl)-D-glucitol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](OCCO)[C@H]1OCCO CRBBOOXGHMTWOC-NPDDRXJXSA-N 0.000 description 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
- MSFSPUZXLOGKHJ-PGYHGBPZSA-N 2-amino-3-O-[(R)-1-carboxyethyl]-2-deoxy-D-glucopyranose Chemical compound OC(=O)[C@@H](C)O[C@@H]1[C@@H](N)C(O)O[C@H](CO)[C@H]1O MSFSPUZXLOGKHJ-PGYHGBPZSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- BJHIKXHVCXFQLS-PUFIMZNGSA-N D-psicose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C(=O)CO BJHIKXHVCXFQLS-PUFIMZNGSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-NQXXGFSBSA-N D-ribulose Chemical compound OC[C@@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-NQXXGFSBSA-N 0.000 description 1
- LKDRXBCSQODPBY-OEXCPVAWSA-N D-tagatose Chemical compound OCC1(O)OC[C@@H](O)[C@H](O)[C@@H]1O LKDRXBCSQODPBY-OEXCPVAWSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical group O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 description 1
- 208000019872 Drug Eruptions Diseases 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 208000033830 Hot Flashes Diseases 0.000 description 1
- 206010060800 Hot flush Diseases 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- 125000003599 L-arabinosyl group Chemical group C1([C@H](O)[C@@H](O)[C@@H](O)CO1)* 0.000 description 1
- WQZGKKKJIJFFOK-DHVFOXMCSA-N L-galactose Chemical compound OC[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-DHVFOXMCSA-N 0.000 description 1
- IAJILQKETJEXLJ-SQOUGZDYSA-N L-guluronic acid Chemical compound O=C[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O IAJILQKETJEXLJ-SQOUGZDYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-OWMBCFKOSA-N L-ribopyranose Chemical group O[C@H]1COC(O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-OWMBCFKOSA-N 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- GZCGUPFRVQAUEE-KAZBKCHUSA-N aldehydo-D-talose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)C=O GZCGUPFRVQAUEE-KAZBKCHUSA-N 0.000 description 1
- PYMYPHUHKUWMLA-YUPRTTJUSA-N aldehydo-L-lyxose Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-YUPRTTJUSA-N 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- NPPRLEYXLWDOKT-WYRLRVFGSA-N benzene-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC1=CC=C(O)C=C1.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O NPPRLEYXLWDOKT-WYRLRVFGSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N beta-D-galactopyranuronic acid Natural products OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-QZABAPFNSA-N beta-D-glucosamine Chemical compound N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-QZABAPFNSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- AEMOLEFTQBMNLQ-YBSDWZGDSA-N d-mannuronic acid Chemical compound O[C@@H]1O[C@@H](C(O)=O)[C@H](O)[C@@H](O)[C@H]1O AEMOLEFTQBMNLQ-YBSDWZGDSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 150000002402 hexoses Chemical group 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- AEMOLEFTQBMNLQ-CLQWQSTFSA-N l-iduronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@@H](O)[C@@H]1O AEMOLEFTQBMNLQ-CLQWQSTFSA-N 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 150000002972 pentoses Chemical group 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
[産業上の利用分野]
本発明は、グリチルレチンおよび/またはその
配糖体とともに特定のハイドロキノンの配糖体を
配合してなる優れた消炎効果を有する皮膚外用剤
に関する。
[従来の技術]
グリメチルレチンは、グリメチルレチン酸とも
呼ばれる構造的にステロイドホルモンに類似する
化合物である。グリチルレチンは動物実験や臨床
実験においても、抗炎症作用のあることが証明さ
れており、消炎を目的として、あるいは、湿疹、
皮膚炎、籌麻疹、薬疹などの治療を目的として化
粧品や医薬品に配合されることが多い。さらに
は、発毛効果もあるといわれており、ヘヤートニ
ツクなどに配合されている例もある。
また、グリチルレチンの配糖体としては、グリ
チルレチンに2分子のグルクロン酸が抱合してな
るグリチルリチンが代表的なものとして挙げられ
るが、このものも同様の効果を有していることが
知られている。
[発明が解決しようとする問題点]
本発明者らは、長年、グリチルレチンおよびそ
の配糖体の薬効について研究を行つてきたが、こ
のたび、驚くべきことに特定のハイドロキノンの
配糖体の併用が、グリチルレチンまたはその配糖
体の薬効を相乗的に亢進することを見いだした。
本発明は、この知見に基づく。
[問題点を解決するための手段]
すなわち、本発明はグリチルメチレンおよび/
またはその配糖体とハイドロキノン−β−D−グ
ルコシド(アルブチン)とを含有することを特徴
とする皮膚外用剤である。
以下、本発明の構成について詳述する。
本発明においては、皮膚外用剤基剤中にグリチ
ルレチンおよび/またはその配糖体が配合され
る。配糖体としてはグリチルリチンがよく知られ
ている。
配合量は皮膚外用剤全量中の0.1〜5重量%の
範囲内であり、0.1重量%未満ではグリチルリチ
ンの薬効が期待できず、5重量%を超えて配合し
ても、それ以上の効果の増大は少なく、不経済で
ある。
なお、グリチルリチンは甘味成分として甘草中
にも存在することが知られているが、本発明にお
いては当然のことながら甘草抽出物として配合さ
れても構わない。
本発明においてグリチルレチンおよび/または
その配糖体とともに皮膚外用剤中に配合され、グ
リチルレチンおよび/またはその配糖体の薬効を
相乗的に亢進するハイドロキノンの配糖体は下記
一般式()で表される。
{式()中、Rは五炭糖残基、六炭糖残基、ア
ミノ糖残基、ウロン酸残基またはそれらのメチル
化物を示す。}
式()中ではRはL−アラビノース、D−ア
ラビノース、D−キシロース、D−リボース、L
−キシルロース、L−リキソース、D−リブロー
スなどの五炭糖の残基、D−グルコース、D−ガ
ラクトース、L−ガラクトース、D−マンノー
ス、D−タロース、D−フルクトース、L−ソル
ボース、D−タガトース、D−プシコースなどの
六炭糖の残基、D−グルコサミン、D−ガラクト
サミン、シアル酸、アミノウロン酸、ムラミン酸
などのアミノ糖の残基、D−グルクロン酸、D−
ガラクツロン酸、D−マンヌロン酸、L−イズロ
ン酸、L−グルロン酸などのウロン酸の残基また
はそれらのメチル化物を示す。
これらの中では、RがD−グルコースの残基、
とくにハイドロキノンにD−グルコースがβ結合
した、すなわち、ハイドロキノン−β−D−グル
コース(一般名;アルブチン)が、もつとも好ま
しい。
アルブチンの配合量は、皮膚外用剤全量中の
0.1〜30重量%、好ましくは6〜20重量%である。
グリチルレチンおよび/またはその配糖体とア
ルブチンとを配合すべき皮膚外用剤は、通常の皮
膚外用剤、たとえば、水溶液系、可溶化系、乳化
系、粉末分散系、水−油2層系、水−油−粉末3
層系など、どのような基剤でもよく、用途も化粧
水、乳液、クリーム、パツクなどの基礎化粧料、
口紅、フアンデーシヨンなどのメーキヤツプ化粧
料、シヤンプー、リンス、ヘアトニツクなどの頭
髪化粧料などの化粧料のほか、医薬品、医薬部外
品など多岐にわたる。
本発明の皮膚外用剤には必要に応じて、本発明
の効果を損なわない範囲で、油分、保湿剤、増粘
剤、防腐剤、乳化剤、乳化防止剤、金属イオン封
鎖剤、紫外線吸収剤、粉末、薬剤、色剤、香料な
どを配合できる。
[実施例]
つぎに、実施例および比較例により本発明をさ
らに詳細を説明する。本発明は、これらにより限
定されるものではない。配合量は重量%である。
実施例1〜3、比較例1〜3
基剤として下記の化粧水を用いて表−1に示す
グリチルレチンおよびアルブチンをそれぞれ配合
した実施例、比較例を製造した。
(基剤)
エタノール 3.0
1,3−ブチレングリコール 10.0
POE(ポリオキシエチレン、以下同じ、15モル)
オレイルエーテル 0.5
オレイルアルコール 01
エチルパラベン 0.1
香 料 0.05
精製水 残余
[Industrial Field of Application] The present invention relates to a skin preparation for external use that has an excellent anti-inflammatory effect and is made by blending a specific hydroquinone glycoside with glycyrrhetin and/or its glycoside. [Prior Art] Glymethylretin, also called glymethylretinoic acid, is a compound structurally similar to steroid hormones. Glycyrrhetin has been proven to have anti-inflammatory effects in animal and clinical experiments, and is used for anti-inflammatory purposes, eczema, etc.
It is often added to cosmetics and pharmaceuticals to treat dermatitis, measles, and drug eruptions. It is also said to have a hair growth effect, and is sometimes included in hair tonics. Furthermore, as a glycoside of glycyrrhetin, glycyrrhizin, which is formed by conjugating two molecules of glucuronic acid to glycyrrhetin, is a typical example, and this is also known to have similar effects. . [Problems to be Solved by the Invention] The present inventors have been conducting research on the medicinal efficacy of glycyrrhetin and its glycosides for many years, and have surprisingly discovered that the combination use of a specific hydroquinone glycoside has been found to synergistically enhance the medicinal efficacy of glycyrrhetin or its glycosides.
The present invention is based on this knowledge. [Means for solving the problems] That is, the present invention provides glycyl methylene and/or
or a glycoside thereof and hydroquinone-β-D-glucoside (arbutin). Hereinafter, the configuration of the present invention will be explained in detail. In the present invention, glycyrrhetin and/or its glycosides are blended into the skin external preparation base. Glycyrrhizin is well known as a glycoside. The blending amount is within the range of 0.1 to 5% by weight of the total amount of the skin external preparation; if it is less than 0.1% by weight, the medicinal efficacy of glycyrrhizin cannot be expected, and even if it is blended in more than 5% by weight, the effect will be further increased. is small and uneconomical. It is known that glycyrrhizin is also present in licorice as a sweet component, but in the present invention, it is of course possible to incorporate it as a licorice extract. In the present invention, the hydroquinone glycoside that is incorporated into the skin external preparation together with glycyrrhetin and/or its glycoside to synergistically enhance the medicinal efficacy of glycyrrhetin and/or its glycoside is represented by the following general formula (). Ru. {In formula (), R represents a pentose residue, a hexose residue, an amino sugar residue, a uronic acid residue, or a methylated product thereof. } In formula (), R is L-arabinose, D-arabinose, D-xylose, D-ribose, L
- Residues of pentose sugars such as xylulose, L-lyxose, D-ribulose, D-glucose, D-galactose, L-galactose, D-mannose, D-talose, D-fructose, L-sorbose, D-tagatose , residues of hexose sugars such as D-psicose, residues of amino sugars such as D-glucosamine, D-galactosamine, sialic acid, aminouronic acid, muramic acid, D-glucuronic acid, D-
Residues of uronic acids such as galacturonic acid, D-mannuronic acid, L-iduronic acid, and L-guluronic acid, or methylated products thereof. Among these, R is a residue of D-glucose;
Particularly preferred is hydroquinone with D-glucose β-bonded, that is, hydroquinone-β-D-glucose (common name: arbutin). The amount of arbutin in the total amount of the skin external preparation is
0.1-30% by weight, preferably 6-20% by weight. The skin external preparation in which glycyrrhetin and/or its glycoside and arbutin should be blended may be a conventional skin external preparation, such as an aqueous solution system, a solubilized system, an emulsion system, a powder dispersion system, a water-oil two-layer system, or a water-oil system. -Oil-Powder 3
Any type of base may be used, including layered bases, and can be used for basic cosmetics such as lotions, emulsions, creams, and packs.
In addition to cosmetics such as makeup cosmetics such as lipsticks and foundations, and hair cosmetics such as shampoos, conditioners, and hair tonics, our products range from pharmaceuticals to quasi-drugs. The skin external preparation of the present invention may contain oil, a humectant, a thickener, a preservative, an emulsifier, an anti-emulsifying agent, a sequestering agent, an ultraviolet absorber, and the like, as necessary, within a range that does not impair the effects of the present invention. Powders, drugs, colorants, fragrances, etc. can be added. [Example] Next, the present invention will be explained in further detail with reference to Examples and Comparative Examples. The present invention is not limited to these. The blending amount is in weight%. Examples 1 to 3, Comparative Examples 1 to 3 Using the following lotion as a base, Examples and Comparative Examples were prepared in which glycyrrhetin and arbutin shown in Table 1 were blended, respectively. (Base) Ethanol 3.0 1,3-butylene glycol 10.0 POE (polyoxyethylene, same below, 15 mol)
Oleyl ether 0.5 Oleyl alcohol 01 Ethylparaben 0.1 Fragrance 0.05 Purified water Residual
【表】
実施例1〜3および比較例1〜2について、実
使用テストを実施して、日焼け後の肌のほてりを
おさえる消炎効果を評価した。試験方法はつぎの
とおりである。
(試験方法)
20〜30代の女性15名6群を被験者として、夏の
海浜で半日、海水浴をした後、それぞれの群に実
施例1〜3および比較例1〜2のいずれかを適宜
2日にわたつて使用してもらい、消炎効果の満足
感を聴取した。
結果を表−2に示す。表−2中の数字は15名中
の満足したと回答した人の数である。アルブチン
にグリチルリチンの消炎効果をさらに増大する効
果があることが明らかである。[Table] Examples 1 to 3 and Comparative Examples 1 to 2 were subjected to actual use tests to evaluate their anti-inflammatory effects in suppressing hot flashes on the skin after sunburn. The test method is as follows. (Test method) Six groups of 15 women in their 20s to 30s were used as subjects, and after swimming at the beach for half a day in summer, each group was given two doses of either Examples 1 to 3 or Comparative Examples 1 to 2 as appropriate. After using the product for several days, we asked them how satisfied they were with the anti-inflammatory effect. The results are shown in Table-2. The numbers in Table 2 are the number of people out of 15 who answered that they were satisfied. It is clear that arbutin has the effect of further increasing the anti-inflammatory effect of glycyrrhizin.
【表】
実施例 4
ナイトクリーム
A セタノール 4.0
ワセリン 7.0
スクワラン 21.0
ステアリン酸モノグリセライド 2.2
POE(20)ソルビタンモノステアレート 2.8
イソプロピルミリステート 6.0
エチルパラベン 0.3
香 料 0.2
B プロピレングリコール 10.0
1,3−ブチレングリコール 5.0
グリチルリチン 0.1
アルブチン 2.0
精製水 残余
(製法)
Aに属する油相部の成分とBに属する水相部の
成分とを、それぞれ別々に加熱溶解し、油相部を
水相部中に混合して乳化し、室温まで冷却してク
リームを得た。
実施例 5
吸水軟こう
ワセリン 40.0
ステアリルアルコール 15.0
モクロウ 15.0
POE(10)オレエート 0.25
ステアリン酸モノグリセライド 0.25
グリチルリチン 3.0
アルブチン 3.0
精製水 残余
(製法)
実施例4に準じる。
実施例
6ヘヤートニツク
エタノール 50.0
POE(8)オレイルエーテル 1.5
ヒノキサチオール 0.1
グリチルリチン 1.0
アルブチン 1.0
エチルパラベン 0.1
香 料 0.05
精製水 残余
(製法)
エタノールの一部にPOEオレイルエーテル、
ヒノキチオール、エチルパラベンおよび香料を溶
解する。別に、精製水およびエタノールの残部に
グリチルリチンとアルブチンを溶解して、さらに
先のエタノール相を加えてヘヤートニツクを得
た。
実施例4〜6は、いずれも消炎効果に優れ、経
日安定性、使用性、安定性にも優れていた。
[発明の効果]
本発明に従つて、グリチルリチンとともにハイ
ドロキノンの配糖体を配合した皮膚外用剤は、グ
リチルリチンの薬効を相乗的に亢進する皮膚外用
剤である。[Table] Example 4 Night cream A Setanol 4.0 Vaseline 7.0 Squalane 21.0 Stearic acid monoglyceride 2.2 POE(20) sorbitan monostearate 2.8 Isopropyl myristate 6.0 Ethylparaben 0.3 Fragrance 0.2 B Propylene glycol 10.0 1,3-butylene glycol 5.0 Glycyrrhizin 0.1 Arbutin 2.0 Purified water Residue (manufacturing method) The oil phase component belonging to A and the aqueous phase component belonging to B are separately heated and dissolved, and the oil phase is mixed into the water phase to emulsify. , and cooled to room temperature to obtain cream. Example 5 Water-absorbing ointment vaseline 40.0 Stearyl alcohol 15.0 Mokuro 15.0 POE(10) oleate 0.25 Stearic acid monoglyceride 0.25 Glycyrrhizin 3.0 Arbutin 3.0 Purified water Residue (manufacturing method) According to Example 4. Example 6 Hair tonic ethanol 50.0 POE(8) oleyl ether 1.5 Hinoxathiol 0.1 Glycyrrhizin 1.0 Arbutin 1.0 Ethylparaben 0.1 Fragrance 0.05 Purified water Remaining (manufacturing method) POE oleyl ether in part of the ethanol,
Dissolve hinokitiol, ethylparaben and fragrance. Separately, glycyrrhizin and arbutin were dissolved in the remaining purified water and ethanol, and the ethanol phase was added to obtain hair tonic. Examples 4 to 6 all had excellent anti-inflammatory effects, and were also excellent in stability over time, usability, and stability. [Effects of the Invention] According to the present invention, an external skin preparation containing glycyrrhizin and a hydroquinone glycoside is an external skin preparation that synergistically enhances the medicinal efficacy of glycyrrhizin.
Claims (1)
と、ハイドロキノン−β−D−グルコシドとを含
有すること特徴とする皮膚外用剤。1. A skin external preparation characterized by containing glycyrrhetin and/or its glycoside and hydroquinone-β-D-glucoside.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4803285A JPS61207308A (en) | 1985-03-11 | 1985-03-11 | External agent for skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4803285A JPS61207308A (en) | 1985-03-11 | 1985-03-11 | External agent for skin |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS61207308A JPS61207308A (en) | 1986-09-13 |
JPH0481962B2 true JPH0481962B2 (en) | 1992-12-25 |
Family
ID=12791969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4803285A Granted JPS61207308A (en) | 1985-03-11 | 1985-03-11 | External agent for skin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS61207308A (en) |
-
1985
- 1985-03-11 JP JP4803285A patent/JPS61207308A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS61207308A (en) | 1986-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH064529B2 (en) | External skin preparation | |
JPS61207316A (en) | External agent for skin | |
JP2720246B2 (en) | External preparation for skin | |
JP3443130B2 (en) | External preparation for skin | |
JPH0899860A (en) | Skin external agent | |
JPH0481962B2 (en) | ||
JPH0296581A (en) | Biotin ester and skin ointment and hair tonic using the ester | |
JPS61227515A (en) | External preparation for skin | |
JP3004707B2 (en) | External preparation for skin | |
JP2805484B2 (en) | External preparation for skin | |
JPS61207307A (en) | External agent for skin | |
JPS61207315A (en) | External agent for skin | |
JPS61210009A (en) | External preparation for skin | |
JP2860902B2 (en) | External preparation for skin | |
JPS61210021A (en) | Hair cosmetic | |
JPS61210010A (en) | External preparation for skin | |
JPS61210008A (en) | External preparation for skin | |
JP3435008B2 (en) | Hair restoration cosmetics | |
JPS61221106A (en) | Epidermic preparation for external use | |
JPH0517332A (en) | Skin medicine for external use | |
JPS61227514A (en) | External preparation for skin | |
JPH0977654A (en) | Skin preparation for external use | |
JPH10147514A (en) | Cosmetic | |
JPS61207311A (en) | External agent for skin | |
JPH0656643A (en) | Skin preparation for external use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |